The Psychedelic Therapy Podcast30 Loka 2020

Darragh Stewart (Inwardbound): My Psychedelic Irish Brother

Before today’s conversation I didn’t know much about Celtic Shamanism.

Today’s guest, Darragh Stewart is a shining beacon of knowledge and joy. As a PhD in plant molecular biology, he has gone all in on plant medicine to support his psychedelic Irish brothers and everyone else who needs to break through the blockages in their lives.

On the show, we talk about how Darragh blends science and spirituality. We get into the origin and structure of Inwardbound Psychedelic Retreats, which take place legally in the Netherlands. We talk about Darragh’s passion for men’s work including the integration group he co-founded called the "Psychedelic Brothers of Ireland." Finally, we get into Celtic Shamanism and efforts to heal the broken lineage of holistic and ancestral healing in Ireland.

One important note: At Inwardbound, all clients go through a strict pre-screening process. In order to attend the retreats, participants cannot have a diagnosed psychiatric illness such as schizophrenia, bipolar, clinical depression or a personality disorder. Similarly, Inwardbound is not able to accommodate participants dealing with serious addiction, substance abuse issues, or who have a personal or family history of psychosis. If this is the case for you, it is recommended that you apply for a clinical research trial.

Links

Inwardbound Retreats
Darragh Steward on Instagram
Email Darragh: Darragh@inwardbound.nl

Timestamps

:06 - How Darragh came to plant medicine from a scientific background
:14 - The origin and structure of Inward Bound retreats
:27 - Men's work with the Psychedelic Brothers of Ireland
:33 - Typical male wounds that come up in psychedelic healing
:41 - Celtic Shamanism and healing broken lineages on the Emerald Isle.
:55 - Darragh speaks to psychedelic therapists

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(64)

Ismail Lourido Ali (MAPS): The Work No Executive Order Can Do

"We can pass 10 executive orders. We can put $500 million for drug development. And if we don't have people who are willing to hold that space... we're not going to get anywhere." - Ismail Lourido Ali...

21 Huhti 1h 10min

Robin Arnott & Sandeep Prakash: Training for Psychedelic Surrender

Can we practice the art of surrender before the first dose?Today on the show Robin Arnott and Dr. Sandeep Prakash explain how SoundSelf evolved from a VR curiosity into a clinically oriented tool that...

25 Huhti 202555min

Joshua White: Who You Gonna Call? Fireside

Imagine you’re in the middle of a psychedelic journey—things are getting intense, and you just need someone to talk to. That’s whereFireside Project comes in. As the world’s first psychedelic peer sup...

13 Helmi 20251h 14min

Tom Feegel: Ibogaine for Cognitive Enhancement

A month ago, I had the privilege of visiting Beond in Cancun, Mexico to experience an ibogaine treatment for cognitive enhancement. Today, I’m joined by Beond CEO Tom Feegel to discuss how this remark...

27 Tammi 20251h 6min

Juan Pablo Capello: A Wakeup Call for Ketamine Telehealth Companies

Today, I’m joined by Juan Pablo Capello, co-founder and former CEO of New Life Health, a telehealth ketamine therapy service launched in 2021. Juan Pablo has raised concerns about low standards of car...

20 Marras 20241h 4min

Natalie Lyla Ginsberg (MAPS): The FDA, MDMA, and the Future of Psychedelic Therapy

Today, we’re exploring a critical issue facing the field of psychedelic medicine: the recent FDA rejection of MAPS’ clinical trials to reschedule MDMA for therapeutic use. This setback affects many of...

28 Loka 20241h 3min

Tricia Eastman & Joseph Barsuglia: Ibogaine is Miracle Grow for the Brain

Today we’re doing something a little different. I’m re-releasing an episode from my personal podcast, Life is a Festival, because it remains one of my favorite interviews ever. This conversation, orig...

18 Loka 20241h 9min

Jennifer Tippett: Understanding Private Practice vs Clinical Trials

After the shocking decision of an advisory committee recommendation that the FDA reject MDMA as a treatment for post-traumatic stress disorder, I wanted to speak to someone who understands the differe...

8 Elo 202446min